HealthEquity, Inc. (HQY) Q3 2026 Earnings Call Transcript
HealthEquity, Inc. (HQY) Q3 2026 Earnings Call Transcript
Fiscal Year: February - January
HealthEquity, Inc. (HQY), listed on the NASDAQ, has a market capitalization of $. As of Jan 05, 2026, the stock is trading at $91.07 per share, offering investors a clear view of its current market value. HealthEquity, Inc. is a prominent player in the industry sector, attracting both institutional and retail investors due to its performance and potential.
With a P/E ratio of 41.85, investors can assess the stock's valuation in comparison to its earnings. A P/E ratio is a crucial indicator for value investors, showing whether the stock is over or undervalued relative to its current earnings. HealthEquity, Inc. also offers a dividend yield of N/A , making it an attractive option for income-focused investors who seek regular dividends.
Our Discounted Cash Flow (DCF) analysis reveals that HealthEquity, Inc. (HQY) may be undervalued compared to its intrinsic worth. However, to see the exact DCF fair value, please Login or Upgrade for access.
The proprietary SS Score for HealthEquity, Inc. is a unique metric that analyzes the company's financial health and growth potential. The score takes into account critical factors such as revenue growth, net income, free cash flow (FCF) compound annual growth rate (CAGR), the trend of shares outstanding, and the debt-to-FCF ratio. This helps investors to make a more informed decision, as an undervalued stock might still have poor financial fundamentals.
To view the detailed SS Score for HealthEquity, Inc., Login or Upgrade for access.
The Price to Free Cash Flow (P/FCF) ratio for HealthEquity, Inc. is 18.84, offering insights into how much investors are paying for the company's free cash flow. A lower P/FCF ratio typically suggests that the stock is undervalued, while a higher ratio may indicate overvaluation.
In summary, HealthEquity, Inc. (HQY) has shown consistent financial performance, as illustrated by the financial charts above, which track its revenue growth, net income, free cash flow, and shares outstanding over the past several years. These metrics provide investors with key insights into the company's past and projected future performance. Investors should use the SS Score alongside the DCF Fair Value to make better-informed decisions about whether to buy or hold the stock.
*This analysis is for informational purposes only and does not constitute investment advice. Always read the company's 10-K filings and do your own research before making any investment decisions.
Whether HealthEquity, Inc. (HQY) is a good stock to buy depends on various factors, including its financial health, market conditions, and your investment strategy. Our analysis indicates that the stock may be undervalued compared to its intrinsic value. However, it is important to assess the SS Score and review the company's fundamentals before making any investment decisions.
The fair value of HealthEquity, Inc. (HQY) is determined through our Discounted Cash Flow (DCF) analysis. This value represents the intrinsic worth of the stock based on its expected future cash flows. To view the specific fair value, consider subscribing to our service for complete access.
The SS Score is a proprietary financial quality metric that assesses factors such as revenue growth, net income, free cash flow growth, and debt levels. It helps investors evaluate the overall financial health of HealthEquity, Inc.. To access the full SS Score, consider upgrading your subscription.
HealthEquity, Inc. is a significant player in the industry sector, with a market capitalization of $ and a competitive P/E ratio of 41.85. Investors should compare these metrics with industry peers to gauge whether HealthEquity, Inc. is outperforming or underperforming within its sector.
HealthEquity, Inc. (HQY) Q3 2026 Earnings Call Transcript
Highlights of the third quarter include: Revenue increased 7% to $322.2 million. Net income per diluted share rose to $0.59 from $0.06 one year ago, and non-GAAP net income per diluted share increased...
HealthEquity, Inc. remains an asset-light growth opportunity, with a $120/share price target supported by strong Q2 FY26 results. HQY's recurring, asset-linked revenues, 70%+ gross margins, and expand...
DRAPER, Utah, Nov. 13, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (Nasdaq: HQY), the nation's largest Health Savings Account (HSA) and consumer-directed benefits administrator, today announced a new ...
DRAPER, Utah, Oct. 14, 2025 (GLOBE NEWSWIRE) -- HealthEquity , Inc. (Nasdaq: HQY), the nation's largest Health Savings Accounts (HSAs) and consumer-directed benefits administrator, today announced two...
DRAPER, Utah, Sept. 25, 2025 (GLOBE NEWSWIRE) -- HealthEquity , Inc. (Nasdaq: HQY), the nation's largest Health Savings Accounts (HSAs) and consumer-directed benefits administrator, today announced th...
HealthEquity reported strong Q2 results with revenue and earnings beats, but valuation remains stretched, justifying a neutral-to-cautiously bullish rating. The company operates in a large, growing he...
HealthEquity, Inc. (NASDAQ:HQY) Q2 2026 Earnings Call September 2, 2025 4:30 PM EDT Company Participants Richard Putnam - Vice President of Investor Relations Scott Cutler - CEO, President & Director...
HealthEquity, Inc. HQY released its second-quarter results after Tuesday's closing bell. Here's a look at the key figures from the quarter.
HealthEquity, Inc. HQY will release earnings results for the second quarter after the closing bell on Tuesday, Sept. 2.
HQY remains a buy for long-term investors, with exceptional economics, high margins, and capital-light growth despite recent multiple contraction. Q1 FY26 results showed strong revenue and earnings gr...
Industry Leader's HSAnswers Wins Multiple Awards to Transform Complex Healthcare Benefits Information to Accessible and Reliable Intel For Millions Industry Leader's HSAnswers Wins Multiple Awards to ...
Funding supports 20 nonprofit organizations focused on physical and mental health, financial literacy, and basic needs as the foundation grows and welcomes a new leader Funding supports 20 nonprofit o...
Insmed, Intuitive Surgical, and IDEXX Laboratories were top contributors, driven by strong drug pipelines, innovation, and robust financial results. We exited UnitedHealth Group due to earnings misses...
DRAPER, Utah, Aug. 06, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation's largest health savings account (“HSA") custodian, today announced plans...
HealthEquity, Inc. HQY posted better-than-expected first-quarter results after Tuesday's closing bell.
Health savings accounts, better known as HSAs, are designed to help people pay for their healthcare and come with some tax advantages. In the video above, HealthEquity CEO Scott Cutler explains the pr...
Scott Cutler, HealthEquity CEO, joins 'Squawk Box' to discuss the company's quarterly earnings results, state of the HSA market, how the tax and spending bill in Congress would impact eligibility, imp...
HealthEquity, Inc. (NASDAQ:HQY) Q1 2026 Earnings Conference Call June 3, 2025 4:30 PM ET Company Participants James M. Lucania - CFO & Executive VP Jon Kessler - Former Director & Special Advisor Ric...
HealthEquity benefits from secular HSA growth and higher interest rates, with Q1 results beating expectations and guidance raised slightly. The core investment thesis is HQY's earnings power is highly...
Highlights of the first quarter include: Revenue of $330.8 million, an increase of 15% compared to $287.6 million in Q1 FY25. Net income of $53.9 million, an increase of 87% compared to $28.8 million ...
HealthEquity (NASDAQ:HQY), a custodian for health savings accounts, is set to announce its earnings on Tuesday, June 3, 2025. Historically, the stock has demonstrated a strong likelihood of positive r...
Below estimates were sourced from SimplyWallSt and are intended for educational purposes only as a baseline for the analysis.
| Year | FCF Estimate | % | # Analysts |
|---|---|---|---|
| 2026 | 408.50M | Analyst x2 | |
| 2027 | 448.00M | 9.67% | Analyst x2 |
| 2028 | 512.50M | 14.40% | Analyst x2 |
| 2029 | 551.98M | 7.70% | Est @7.7% |
| 2030 | 583.94M | 5.79% | Est @5.8% |
| 2031 | 611.88M | 4.79% | Est @4.8% |
| 2032 | 636.90M | 4.09% | Est @4.1% |
| 2033 | 659.78M | 3.59% | Est @3.6% |
| 2034 | 679.77M | 3.03% | Est @3.0% |
| 2035 | 698.85M | 2.81% | Est @2.8% |
Below are the FCF estimates with the discount factor and the calculated present value with the terminal value that led the results above.
| Year | FCF | Discount Factor | PV of Future FCF |
|---|---|---|---|
| 2024A | 241.13M | 1.00 | 241.13M |
| 2025A | 337.77M | 1.00 | 337.77M |
| 2026E | 408.50M | 1.08 | 378.77M |
| 2027E | 448.00M | 1.16 | 385.16M |
| 2028E | 512.50M | 1.25 | 408.54M |
| 2029E | 551.98M | 1.35 | 407.99M |
| 2030E | 583.94M | 1.46 | 400.19M |
| 2031E | 611.88M | 1.57 | 388.82M |
| 2032E | 636.90M | 1.70 | 375.26M |
| 2033E | 659.78M | 1.83 | 360.44M |
| 2034E | 679.77M | 1.97 | 344.34M |
| 2035E | 698.85M | 2.13 | 328.24M |
| Terminal | 13.39B | 2.13 | 6.29B |
The information given by Studying Stocks and provided in the web and/or mobile applications (Platforms) is only factual information and should not be considered financial advice.
Any information contained in this website has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
When creating an account, you acknowledge that you are:
We retain the right to cancel your account for any reason, or refuse your account creation request.
The information on our Platforms is not comprehensive and is intended to provide a summary of the subject matter covered. While we use all reasonable attempts to ensure the accuracy and completeness of the data and information on our Platforms, to the extent permitted by law, we make no warranty regarding the information on these Platforms. You should monitor any changes to the information contained on these Platforms.
Furthermore we make no commitments in regards to the minimum amount of uptime that our platforms will maintain, although we will make ever reasonable attempt to ensure that the platforms are operational. Therefore, any reference of "latest", "current" and related words about the financial data presented here may not be up to date with the financial markets or represent reality of the information.
We are not liable to you or anyone else if interference with or damage to your computer systems occurs in connection with the use of these Platforms or a linked website. You must take your own precautions to ensure that whatever you select for your use from our Platforms is free of viruses or anything else (such as worms or Trojan horses) that may interfere with or damage the operations of your computer systems.
We may, from time to time and without notice, change or add to the Platforms (including the Terms) or the information, products or services described in it. However, we do not undertake to keep the Platforms updated. We are not liable to you or anyone else if errors occur in the information or the Platforms is not up-to-date.
Our Platforms may contain links to websites operated by third parties. Those links are provided for convenience and may not remain current or be maintained. Unless expressly stated otherwise, we do not endorse and are not responsible for the content on those linked websites and have no control over or rights in those linked websites.
These Platforms are for your personal, non-commercial use only. You may not modify, copy, distribute, transmit, display, perform, reproduce, publish, license, commercially exploit, create derivative works from, transfer, or sell any Content, software, products or services contained within these Platforms. You may not use these Platforms, or any of its Content, to further any commercial purpose, including any advertising or advertising revenue generation activity on your own website.
You must not do any act that we would deem to be inappropriate, is unlawful or is prohibited by any laws applicable to these Platforms, including but not limited to:
If we allow you to post any information to our Platforms, we have the right to take down this information at our sole discretion and without notice.
To the maximum extent permitted by law, we make no warranties or representations about these Platforms or the Content, including but not limited to warranties or representations that they will be complete, accurate or up-to-date, that access will be uninterrupted or error-free or free from viruses, or that these Platforms will be secure.
We reserve the right to restrict, suspend or terminate without notice your access to these Platforms, any Content, or any feature of these Platforms at any time without notice and we will not be responsible for any loss, cost, damage or liability that may arise as a result.
To the maximum extent permitted by law, in no event shall we be liable for any direct and indirect loss, damage or expense – irrespective of the manner in which it occurs – which may be suffered due to your use of our Platforms and/or the information or materials contained on it, or as a result of the inaccessibility of these Platforms and/or the fact that certain information or materials contained on it are incorrect, incomplete or not up-to-date.
This website utilises cookies. If you do not have cookies enabled in your web browser some functions of the site may not work as intended.